A need to reconfigure and an opportunity to transform
The in vitro diagnostics industry has been at the forefront of the fight against SARS-CoV-2 and medicine’s response to cases of severe COVID-19 disease.
In the February issue of Pathology in Practice, Mark Reed from Pro-Lab Diagnostics provides a commercial perspective and overview of the unprecedented times experienced over the past 12 months.
In addition, Doris-Ann Williams, the British In Vitro Diagnostics Association (BIVDA) Chief Executive, discusses how IVDs will be regulated in a newly independent UK after being regulated under the IVD Directive for the past 20 years, and the effects this may have on industry and clinical laboratories in the UK.
Access the February digital issue here.
Other News
Featured Supplier
Often, better healthcare is less about pioneering breakthroughs or techniques and more about finding ways to better use existing technology to improve outcomes. And that’s what Una Health is all about: taking an innovative approach to diagnostics to challenge traditional pathways and improve patient outcomes.
We specialise in Pathology and...
Upcoming Events
COVID-19 - The Infection Challenging the World
Online
11-14 May 2021
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
